EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Molecular alterations in high‐grade neuroendocrine tumors of the small intestine

Agathe Hercent iD, Julien Masliah-Planchon, David Cohen, Remy Nicolle, Jean-Yves Scoazec, Philippe Ruszniewski, Ivan Bièche, Louis de Mestier, Anne Couvelard, Jerome Cros iD

The Journal of Pathology · 2026

DOI: 10.1002/path.70004 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Pathology, 2026. Verfasst von Agathe Hercent und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, FHU MOSAIC, Beaujon-Bichat Hospitals, AP-HP, Université Paris-Cité, Paris, France. Hauptthemen laut MEDLINE: Intestinal Neoplasms, Neuroendocrine Tumors, Biomarkers, Tumor, Intestine, Small. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Société Nationale Francaise de gastro-Entérologie (SNFGE), Groupe de Tumeurs Neuro Endocrines (GTE), Société Nationale Française de Gastro-Entérologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐grade neuroendocrine tumors of the small intestine are separated into two groups: well‐differentiated neuroendocrine tumors (NETs, high‐grade) and poorly differentiated neuroendocrine carcinomas (NECs). They represent very rare entities, with few molecular data available, and are very challenging to treat. In this study we aimed to describe the molecular profile of these tumors and their spatial and temporal heterogeneity. We collected a national multicenter cohort of high‐grade NETs (14 patients) and NECs (11 patients). DNA and RNA were extracted and somatic point mutations, copy number variations, and gene expression levels were studied using high‐throughput sequencing of a panel of 571 genes and RNA sequencing, respectively. Additional samples to study spatial or temporal heterogeneity were available for 12 patients, leading to a total of 42 samples analyzed. Differential diagnostic markers were confirmed by immunohistochemistry. NECs resemble their counterparts in other organs, with a relatively high tumor mutational burden (TMB) and frequent alteration of TP53 and RB1 , together with organ‐specific alterations such as APC . In contrast, high‐grade NETs resemble low‐grade NETs, with a low TMB but frequent chromosomic alterations. Transcriptomic analysis confirmed that high‐grade NETs and NECs are two distinct entities, with specific drivers. Serotonin pathway markers were the most efficient to discriminate high‐grade ileal NETs from NECs. Despite variations in the proliferation index, NETs showed little spatial and temporal heterogeneity, suggesting that epigenetic mechanisms play a crucial role in tumor progression. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal NeoplasmsNeuroendocrine TumorsBiomarkers, TumorIntestine, SmallCarcinoma, NeuroendocrineHumansMaleFemaleMiddle AgedAgedMutationAdultNeoplasm GradingDNA Copy Number VariationsHigh-Throughput Nucleotide SequencingGene Expression Profiling

Stichwörter der Autor:innen

NECNETheterogeneityhigh grade tumorileal neuroendocrine carcinomaileal neuroendocrine tumorsmolecular profile

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, FHU MOSAIC, Beaujon-Bichat Hospitals, AP-HP, Université Paris-Cité, Paris, France.
  • Department of Genetics, Bichat Hospital (APHP), University of Paris Cité, Paris, France.
  • INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France.
  • Pharmacogenomics Department, Institut Curie, PSL Research University, Paris, France.
  • Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.

ORCID-Profile: Agathe Hercent, Jerome Cros

Förderung

  • Société Nationale Francaise de gastro-Entérologie (SNFGE)
  • Groupe de Tumeurs Neuro Endocrines (GTE)
  • Société Nationale Française de Gastro-Entérologie

Zitieren

APA

Hercent, A., Masliah-Planchon, J., Cohen, D., Nicolle, R., Scoazec, J. Y., Ruszniewski, P., Bièche, I., de Mestier, L., Couvelard, A., & Cros, J. (2026). Molecular alterations in high‐grade neuroendocrine tumors of the small intestine. The Journal of Pathology. https://doi.org/10.1002/path.70004

Vancouver

Hercent A, Masliah-Planchon J, Cohen D, Nicolle R, Scoazec JY, Ruszniewski P, et al. Molecular alterations in high‐grade neuroendocrine tumors of the small intestine. The Journal of Pathology. 2026. doi:10.1002/path.70004

BibTeX
@article{Hercent2026,
  author = {Hercent, Agathe and Masliah-Planchon, Julien and Cohen, David and Nicolle, Remy and Scoazec, Jean-Yves and Ruszniewski, Philippe and Bièche, Ivan and de Mestier, Louis and Couvelard, Anne and Cros, Jerome},
  title = {Molecular alterations in high‐grade neuroendocrine tumors of the small intestine},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70004}
}
Kostenlos starten →